Radiol Bras.
rb
Radiologia Brasileira
Radiol Bras
1678-7099
Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
Resumo
Objetivo:
Uma meta-análise foi realizada para estabelecer o desempenho diagnóstico da ressonância magnética com imagem ponderada em difusão (DWI) na discriminação de linfonodos torácicos malignos de benignos.
Materiais e Métodos:
MEDLINE, EMBASE e Web of Science foram sistematicamente pesquisados até abril de 2020. Foram incluídos estudos que relatavam o uso de DWI na avaliação de linfonodos torácicos. Sensibilidade, especificidade, razão de chances de diagnóstico, valores preditivos positivos e negativos e área sob a curva (AUC) foram calculados.
Resultados:
Foram encontrados 356 linfonodos mediastinais de 214 pacientes nos seis estudos incluídos. DWI produziu sensibilidade e especificidade combinadas de 92% (intervalo de confiança 95% [IC 95%]: 71-98%) e 93% (IC 95%: 79-98%), respectivamente. A razão de verossimilhança positiva foi de 13,2 (IC 95%: 4,0-43,8), a razão de verossimilhança negativa foi de 0,09 (IC 95%: 0,02-0,36); A razão de chances de diagnóstico foi de 149 (IC 95%: 18-1.243). A DWI teve uma AUC de 0,97 (IC 95%: 0,95-0,98).
Conclusão:
DWI é uma técnica reprodutível que demonstrou alta acurácia na diferenciação de estados malignos e benignos nos linfonodos torácicos.
INTRODUCTION
A wide range of diseases are associated with thoracic lymphadenopathy(1). Evaluating enlarged lymph nodes is clinically essential for treatment planning and for the prediction of the prognosis(2). The main concern when evaluating a patient with a novel finding of enlarged thoracic lymph nodes, without a previous diagnosis, is the determination of whether the etiology is malignant or benign.
Several techniques and procedures are available to assess thoracic lymphadenopathy. Although biopsy is the recommended method for diagnosis, the risks associated with the procedure and sampling error have driven clinicians to search for noninvasive diagnostic methods(3,4). Computed tomography (CT) is typically the technique of choice for thoracic assessment and for the morphological description of enlarged lymph nodes. Chest CT is frequently used in the investigation of patient complaints of respiratory symptoms, often revealing enlarged thoracic lymph nodes. However, CT cannot accurately differentiate benign from malignant lymph nodes and exposes patients to radiation(5,6). Positron emission tomography/CT (PET/CT) performed with fluorine-18-fluorodeoxyglucose (18F-FDG) relies on the biochemical mechanism of increased glucose uptake by the malignant cells to differentiate malignant from benign lymph nodes, appearing to be better than is CT alone(7). However, PET/CT is often unavailable and frequently provides false-positive results(8,9). Diffusion-weighted magnetic resonance imaging (DWI) is a noninvasive, radiation-free tool that does not require the use of exogenous contrast agents, is accessible, and is easy to incorporate into the clinical routine. Over the last decade, DWI has demonstrated good diagnostic performance in multifarious tumors of various etiologies(10-14). The aim of this study was to determine the performance of DWI in distinguishing between malignant and benign thoracic lymph nodes.
MATERIALS AND METHODS
This meta-analysis was conducted in accordance with the criteria established in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement(15). The International Prospective Register of Systematic Reviews was searched in order to identify unpublished systematic reviews. Because the study utilized anonymous data from previously published studies and thus presented no risk to the subjects, the institutional review board waived the requirement for written informed consent.
Search strategy
We performed searches of the literature in the databases MEDLINE (via PubMed), EMBASE, and Web of Science, from their inception through April 2020. The search strategy included the use of the following terms and medical subject headings: “Magnetic Resonance Imaging” OR “MRI” OR “MR imaging” AND “mediastinum” OR “chest” OR “thorax” OR “thoracic” OR “hilar” AND “lymph nodes” OR “lymphadenopathy”. The strategies for other databases are available upon request. Articles published in English, Portuguese, and Spanish were included. We also performed manual searches of the references of the articles selected. Disagreements regarding the selection of articles were resolved by consensus.
Eligibility criteria
The criteria for the inclusion of articles were the following: reporting results of magnetic resonance imaging (MRI) evaluation of thoracic lymph nodes; reporting apparent diffusion coefficient (ADC) measurements; and having used the histopathological analysis as the reference standard. Studies with missing or poor-quality data were excluded, as were those not involving DWI of the chest, those that were nondiagnostic studies, and those that were published as a conference abstract, letter, review, animal study, comment, or case report. The following focused questions were addressed: What is the applicability of DWI of thoracic lymph nodes in differentiating between malignant and benign lymph nodes in patients without a prior diagnosis?; What has been investigated regarding the application of DWI in thoracic lymph node evaluation?; What results were obtained by the researchers?
Data extraction
Two of the authors, working independently, evaluated the titles and abstracts of the articles retrieved, applying the inclusion and exclusion criteria. Disagreements were resolved by consensus with the help of a third author. The same reviewers independently evaluated the full texts of the articles and made their selection in accordance with the eligibility criteria. Studies accepted for analysis were assessed in accordance with the PRISMA guidelines. The following data were collected: first author; year of publication; study design; country of patient recruitment; patient demographic characteristics (age and gender); reference standard (histopathological analysis of surgical resection/biopsy sample or radiological follow-up); technical details of the MRI scanner, MRI characteristics (ADC values and number of nodes assessed); final pathological confirmation of the nature of the lymphadenopathy; and the prevalence of malignant and benign lymph nodes.
Study quality assessment
The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool(16) was the instrument of choice to evaluate the risk of bias of each study. The QUADAS-2 tool facilitates the process of evaluating studies, on the basis of four main domains: patient selection; index test(s); reference standard; and flow and timing. Its result is presented in the form of a graph showing whether the risk of bias or inapplicability is “low”, “unclear”, or “high”.
Statistical analysis
The pooled sensitivities and specificities, together with the respective 95% confidence intervals (95% CIs), were calculated by using random-effects analysis. The pooled positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (DOR) were also obtained. Summary receiver operating characteristic curves were constructed, and the areas under the curve (AUCs) were obtained. To assume an approximate normal distribution, we used the distribution of logit-transformed sensitivity and specificity, as well as that of the natural logarithm of DOR(17-19). A Deeks’ funnel plot was used in order to display any publication bias. All statistical analyses were performed with Stata software, v. 15.0 (Stata Corp., College Station, TX, USA).
RESULTS
The search resulted in 864 potentially relevant citations from the electronic databases. After duplicate titles had been removed, 862 articles remained. During the screening of the titles and abstracts, another 848 articles were excluded. We evaluated the full texts of 18 remaining articles, 12 of which were thus excluded, yielding 6 articles that met our inclusion criteria(20-25). Figure 1 depicts the article selection process.
Figure 1
PRISMA flow chart detailing the search and article selection processes.
Figure 2 shows the QUADAS-2 results. Although most of the included studies had a low risk of bias, the chance of possible confounders was greater in two domains: flow and timing; and patient selection. In four studies(21-23,25), the authors do not mention the time between histological analysis and acquisition of the imaging test. In two studies(8,23), patients with previously identified PET/CT alterations were selected.
Figure 2
QUADAS-2 summary. The overall QUADAS-2 score for the articles selected suggests that they were of high quality.
The articles selected for review evaluated a collective total of 356 thoracic lymph nodes in 214 patients (Table 1). The underlying non-neoplastic pathologies, as described by the authors, ranged from sarcoidosis to reactive lymphoid hyperplasia, necrotizing granulomatous lymphadenitis, tuberculous nodes, pneumoconiosis/silicosis, Langerhans cell histiocytosis, and histoplasmosis. Malignant thoracic lymph nodes were metastases of small cell lung cancer, non-small cell lung cancer, or lymphoma, as well as metastatic lymph nodes from distant sites or leukemia. Two studies did not provided specified diagnosis per lymph node, justifying that choice by stating that there were no significant differences between the etiologies of the malignant lymph nodes and those of the benign lymph nodes(8,25). The selected studies enrolled patients variously in Europe(25), Asia(20,23,24,26), and Africa(21,22). Table 1 presents a summary of the studies.
Table 1
Summary of the studies selected.
Reference
Country
Study design
Number of patients
Total number of MLNs (benign MLNs)
Field strength
b-value(s/mm2)
Result
TP
FP
FN
TN
Kosucu et al.(20)
Turkey
Prospective
35
91 (72)
1.5 T
50; 400
19
0
0
72
Razek et al.(22)
Egypt
Prospective
35
35 (7)
1.5 T
0; 300; 600
27
2
1
5
Razek et al.(21)
Egypt
Retrospective
32
29 (9)
1.5 T
0; 300; 600
20
2
0
7
Usuda et al.(23)
Japan
Prospective
23
23 (16)
1.5 T
0; 800
5
0
2
16
Qi et al.(24)
China
Prospective
35
91 (49)
1.5 T
0; 50; 100; 200; 400; 600; 800; 1,000
32
5
10
44
Sigovan et al.(25)
France
Prospective
54
87 (65)
3.0 T
0; 400; 800
15
10
7
55
MLNs, mediastinal lymph nodes; TP, true-positive; FP, false-positive; FN, false-negative; TN, true-negative.
Of the 356 thoracic lymph nodes evaluated, 211 (59.2%) were found to be benign and 145 (40.8%) were found to be malignant. The pooled sensitivity and specificity of DWI was 92% (95% CI: 71-98%) and 93% (95% CI: 79-98%), respectively, as shown in Figure 3. The sensitivity and specificity of DWI showed strong heterogeneity (I2 = 82.5% and 83.6%, respectively). A forest plot of the DOR values was used in order to evaluate the determination of heterogeneity caused by a non-threshold effect. In the selected studies, heterogeneity was indicated by a nonlinear distribution of the DOR values. The positive and negative likelihood ratios were 13.2 (95% CI: 4.0-43.8) and 0.09 (95% CI: 0.02-0.36), respectively, as shown in Figure 4. The DOR was 149 (95% CI: 18-1,243). As can be seen in Figure 5, DWI had an AUC of 0.97 (95% CI: 0.95-0.98).
Figure 3
Forest plots of the sensitivity and specificity of DWI for differentiating between malignant and benign thoracic lymph nodes. Heterogeneity was high, as evidenced by the I2 value, which was 82%, values over 75% being considered indicative of high heterogeneity.
Figure 4
Conditional probability plot of the ability of DWI to differentiate between malignant and benign mediastinal lymph nodes. LR, likelihood ratio.
Figure 5
Receiver operating characteristic curve for DWI. AUC suggest a high diagnostic performance. Numbers within circles represent the studies referenced.
DISCUSSION
Recent studies conducted in Brazil have highlighted the importance of CT in the evaluation of thoracic diseases(27-34). However, the role of DWI has been little emphasized. DWI is a noninvasive technique that measures the water diffusion in biological tissues. The natural motion of water can be measured as signal loss and expressed as an ADC value. The ADC depends on the presence of obstacles to diffusion (Brownian motion), such as increased cellularity and macromolecules that can be found in neoplastic/malignant disease(35,36). Lymph nodes affected by metastasis show lower ADC values than do benign tumors. Malignant tumors-due to enlarged nuclei, hyperchromatic cells, angulated nuclear contours, and hypercellularity-have reduced water diffusion in their extracellular and intracellular domains(37,38). Thoracic analysis utilizing DWI has progressed in recent years. In comparison with CT, it has the advantages of not exposing patients to radiation, not requiring the administration of intravenous contrast, and short examination times. In comparison with 18F-FDG-PET/CT, the use of DWI has those same benefits, as well as being more widely available and producing fewer false-positive results(8). When lymph nodes contain inflammation, 18F-FDG PET/CT is likely to show false-positive results, whereas it is likely to show false-negative results when lymph nodes contain small amounts of cancer cells(39). All of the included studies reported results showing that DWI can be useful in differentiating between lymph nodes with metastasis and those without, with good accuracy in patients with enlarged thoracic lymph nodes. The studies also showed that the ADC values were significantly lower for benign lymph nodes than for malignant lymph nodes.
Whereas other studies on the use of DWI for thoracic lymph nodes have focused on the nodal stage assessment for patients with previously identified primary tumors, ours is the first study to systematically attempt to clarify the quantitative distinction between malignant and benign lymph nodes through the use of DWI in patients without an initial diagnosis(40,41). This ability of DWI is relevant because it allows diseases that can manifest primarily in lymph nodes, such as lymphoma and sarcoidosis, to be differentiated. Previous articles have demonstrated that DWI and 18F-FDG-PET/CT both have good diagnostic performance in evaluating lymph nodes in non-small cell lung cancer. In the preoperative staging of mediastinal and hilar lymph nodes(39), DWI has been found to show a specificity for N staging of 95%, significantly higher than the 89% observed for 18F-FDG-PET/CT(39). One study(23) reported that the specificity of DWI was 100%, suggesting that this modality can give fewer false-negative results for malignant lymph nodes, excluding mediastinal lymph node metastases. The authors of that study compared DWI and 18F-FDG-PET/CT in thoracic lymph nodes with 18F-FDG accumulation (maximum standardized uptake value > 3) in 33 patients, demonstrating that the ADC value was significantly lower in malignant than in benign mediastinal lymph nodes, although the maximum standardized uptake value did not differ significantly between the two. Sigovan et al.(25) and Qi et al.(24) demonstrated that DWI had a specificity superior than 80% for the diagnosis of malignant lymph nodes. Sigovan et al.(25) tested the applicability of ADC mapping, as well as the relative contrast ratio between the signal intensity of a lesion (lymph node) and that of muscle, using a 3-T scanner, unlike the other five studies included, all of which employed 1.5-T scanners. The authors found no significant difference between the diagnostic accuracy of ADC mapping and that of the relative contrast ratio. Qi et al.(24) investigated the value of an intravoxel incoherent motion diffusion model to the same purpose as the other studies, with the application of eight b-values (0, 50, 100, 200, 400, 600, 800, and 1,000 s/mm2), combining perfusion and diffusion in order to characterize tissues, whereas the use of a low b-value to calculate the ADC is subject to errors introduced by the microcirculation of blood. Those authors showed that the combination of ADC mapping and the microvascular volume fraction provides diagnostic performance better than that of ADC mapping (mono-exponential model DWI) alone for discriminating between malignant and benign thoracic lymph nodes. Kosucu et al.(20) found that the use of a quantitative measure such as the ADC is more reliable than is the qualitative description of affected nodes, because malignant and benign lymph nodes can both show heterogeneous signal intensity. The authors reported that, of the malignant lymph nodes identified, 47.36% were hypointense on DWI and 73.68% were hypointense on ADC maps, compared with 80.55% and 79.16% of the benign lymph nodes, respectively. In 2011, Razek et al.(22) analyzed the role of DWI in predicting malignant and benign mediastinal lymph nodes. In a subsequent study, conducted in 2015, the same research team compared 18F-FDG-PET/CT and DWI for the analysis of mediastinal lymphadenopathy in children (2-15 years of age)(21). In the 2011 study, the authors found that DWI had an accuracy of DWI of 83.9%, a sensitivity of 96.4%, a specificity of 71.4%, a negative predictive value of 95.2%, and a positive predictive value of 77.1%, compared with 93.1%, 100%, 77.8%, 90.9%, and 100%, respectively, in the 2015 study, showing that the ADC map is a promising parameter that can help in the differentiation between malignant and benign lymph nodes, which is highly desirable in children, in whom the risks of radiation exposure are greater.
Cutoff values for ADC parameters were not the same in all of the studies included in our meta-analysis. This variation may be explained by the ADC values for lymph nodes due to the type of diffusion data acquisition and the b-values employed. Variations in b-values can change the diffusion sensitivity. The highest sensitivity values, of 96.4% and 100%, were seen in the previously cited studies conducted in 2011 and 2015, respectively(21,22). The lowest sensitivity values, of 68.2% and 62.2%, were seen in the studies conducted by Sigovan et al.(25) and Kosucu et al.(20), respectively. That could be explained by the fact that malignant and benign lymph nodes of different pathologies were compared. However, the use of free-breathing DWI sequences can improve diagnostic performance for assessing mediastinal lymph nodes over conventional DWI in terms of the signal-to-background ratio, fat suppression, and the number of motion artifacts(42). The modalities employed among the studies evaluated in our meta-analysis included cardiac gating(24), respiratory-triggering(20,23), and free-breathing(21,25). Nevertheless, DWI has some limitations, such as the fact that benign lesions can exhibit restricted diffusion, thus mimicking malignant lesions(43,44), abscesses, and thrombi(45,46).
The DWI technique is quite useful, particularly for determining the status of mediastinal lymph nodes. It can reduce the frequency of unnecessary invasive procedures, yielding a less harmful diagnostic pathway. Although there is a need for further studies addressing interobserver reproducibility, as well as for cost-effectiveness analyses, we encourage the routine use of ADC mapping as an adjunct tool for the diagnosis of thoracic lymphadenopathy.
REFERENCES
1
1 Mennini ML, Catalano C, Del Monte M, et al. Computed tomography and magnetic resonance imaging of the thoracic lymphatic system. Thorac Surg Clin. 2012;22:155-60.
Mennini
ML
Catalano
C
Del Monte
M
Computed tomography and magnetic resonance imaging of the thoracic lymphatic system
Thorac Surg Clin
2012
22
155
160
2
2 Passlick B. Detection of disseminated lung cancer cells in lymph nodes by monoclonal antibodies: impact on staging and prognosis. Ann Ital Chir. 1999;70:839-40.
Passlick
B
Detection of disseminated lung cancer cells in lymph nodes by monoclonal antibodies: impact on staging and prognosis
Ann Ital Chir
1999
70
839
840
3
3 Gupta S, Seaberg K, Wallace MJ, et al. Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics. 2005;25:763-86.
Gupta
S
Seaberg
K
Wallace
MJ
Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations
Radiographics
2005
25
763
786
4
4 Goldberg SN, Raptopoulos V, Boiselle PM, et al. Mediastinal lymphadenopathy: diagnostic yield of transbronchial mediastinal lymph node biopsy with CT fluoroscopic guidance-initial experience. Radiology. 2000;216:764-7.
Goldberg
SN
Raptopoulos
V
Boiselle
PM
Mediastinal lymphadenopathy: diagnostic yield of transbronchial mediastinal lymph node biopsy with CT fluoroscopic guidance-initial experience
Radiology
2000
216
764
767
5
5 Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med. 2004;45:1509-18.
Torabi
M
Aquino
SL
Harisinghani
MG
Current concepts in lymph node imaging
J Nucl Med
2004
45
1509
1518
6
6 Arita T, Matsumoto T, Kuramitsu T, et al. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest. 1996;110:1004-8.
Arita
T
Matsumoto
T
Kuramitsu
T
Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen
Chest
1996
110
1004
1008
7
7 Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 1997;202:441-6.
Steinert
HC
Hauser
M
Allemann
F
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
Radiology
1997
202
441
446
8
8 Usuda K, Sagawa M, Motono N, et al. Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer. Ann Surg Oncol. 2013;20:1676-83.
Usuda
K
Sagawa
M
Motono
N
Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer
Ann Surg Oncol
2013
20
1676
1683
9
9 Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008;135:816-22.
Nomori
H
Mori
T
Ikeda
K
Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results
J Thorac Cardiovasc Surg
2008
135
816
822
10
10 Gilet AG, Kang SK, Kim D, et al. Advanced renal mass imaging: diffusion and perfusion MRI. Curr Urol Rep. 2012;13:93-8.
Gilet
AG
Kang
SK
Kim
D
Advanced renal mass imaging: diffusion and perfusion MRI
Curr Urol Rep
2012
13
93
98
11
11 Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001;186 Suppl. 1:S25-35.
Schaefer
PW
Applications of DWI in clinical neurology
J Neurol Sci.
2001
186
Suppl. 1
S25
S35
12
12 Mertan FV, Berman R, Szajek K, et al. Evaluating the role of mpMRI in prostate cancer assessment. Expert Rev Med Devices. 2016;13: 129-41.
Mertan
FV
Berman
R
Szajek
K
Evaluating the role of mpMRI in prostate cancer assessment
Expert Rev Med Devices
2016
13
129
141
13
13 Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted MR imaging-preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570-7.
Matoba
M
Tonami
H
Kondou
T
Lung carcinoma: diffusion-weighted MR imaging-preliminary evaluation with apparent diffusion coefficient
Radiology
2007
243
570
577
14
14 Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003;226:71-7.
Taouli
B
Vilgrain
V
Dumont
E
Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients
Radiology
2003
226
71
77
15
15 Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Moher
D
Liberati
A
Tetzlaff
J
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
PLoS Med
2009
6
e1000097
16
16 Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-36.
Whiting
PF
Rutjes
AWS
Westwood
ME
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Ann Intern Med
2011
155
529
536
17
17 Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-43.
Hanley
JA
McNeil
BJ
A method of comparing the areas under receiver operating characteristic curves derived from the same cases
Radiology
1983
148
839
843
18
18 Kiewiet JJS, Leeuwenburgh MMN, Bipat S, et al. A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis. Radiology. 2012;264:708-20.
Kiewiet
JJS
Leeuwenburgh
MMN
Bipat
S
A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis
Radiology
2012
264
708
720
19
19 Glas AS, Lijmer JG, Prins MH, et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56: 1129-35.
Glas
AS
Lijmer
JG
Prins
MH
The diagnostic odds ratio: a single indicator of test performance
J Clin Epidemiol
2003
56
1129
1135
20
20 Kosucu P, Tekinbas C, Erol M, et al. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging. J Magn Reson Imaging. 2009;30:292-7.
Kosucu
P
Tekinbas
C
Erol
M
Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging
J Magn Reson Imaging
2009
30
292
297
21
21 Razek AAKA, Gaballa G, Elashry R, et al. Diffusion-weighted MR imaging of mediastinal lymphadenopathy in children. Jpn J Radiol. 2015;33:449-54.
Razek
AAKA
Gaballa
G
Elashry
R
Diffusion-weighted MR imaging of mediastinal lymphadenopathy in children
Jpn J Radiol
2015
33
449
454
22
22 Razek AAKA, Elkammary S, Elmorsy AS, et al. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging. 2011;29:167-72.
Razek
AAKA
Elkammary
S
Elmorsy
AS
Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging
Magn Reson Imaging
2011
29
167
172
23
23 Usuda K, Maeda S, Motono N, et al. Diagnostic performance of diffusion-weighted imaging for multiple hilar and mediastinal lymph nodes with FDG accumulation. Asian Pac J Cancer Prev. 2015;16:6401-6.
Usuda
K
Maeda
S
Motono
N
Diagnostic performance of diffusion-weighted imaging for multiple hilar and mediastinal lymph nodes with FDG accumulation
Asian Pac J Cancer Prev
2015
16
6401
6406
24
24 Qi LP, Yan WP, Chen KN, et al. Discrimination of malignant versus benign mediastinal lymph nodes using diffusion MRI with an IVIM model. Eur Radiol. 2018;28:1301-9.
Qi
LP
Yan
WP
Chen
KN
Discrimination of malignant versus benign mediastinal lymph nodes using diffusion MRI with an IVIM model
Eur Radiol
2018
28
1301
1309
25
25 Sigovan M, Akl P, Mesmann C, et al. Benign and malignant enlarged chest nodes staging by diffusion-weighted MRI: an alternative to mediastinoscopy? Br J Radiol. 2018;91:20160919.
Sigovan
M
Akl
P
Mesmann
C
Benign and malignant enlarged chest nodes staging by diffusion-weighted MRI: an alternative to mediastinoscopy?
Br J Radiol
2018
91
20160919
20160919
26
26 Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr. 2010;34:1-8.
Nakayama
J
Miyasaka
K
Omatsu
T
Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient
J Comput Assist Tomogr
2010
34
1
8
27
27 Geraldino ACC, Marchiori E. Cavitary rheumatoid nodules: an unusual pulmonary finding. Radiol Bras. 2019;52:203-4.
Geraldino
ACC
Marchiori
E
Cavitary rheumatoid nodules: an unusual pulmonary finding
Radiol Bras
2019
52
203
204
28
28 Tibana TK, Camilo DMR, Nunes TF, et al. Congenital lobar emphysema. Radiol Bras. 2019;52:62-3.
Tibana
TK
Camilo
DMR
Nunes
TF
Congenital lobar emphysema
Radiol Bras
2019
52
62
63
29
29 Santos RFT, Tibana TK, Adôrno IF, et al. Mounier-Kuhn syndrome: an unusual cause of bronchiectasis. Radiol Bras. 2019;52:130-1.
Santos
RFT
Tibana
TK
Adôrno
IF
Mounier-Kuhn syndrome: an unusual cause of bronchiectasis
Radiol Bras
2019
52
130
131
30
30 Avelino EBP, Verza L, Neves T, et al. Lymphocytic interstitial pneumonia and pulmonar amyloidosis in Sjögren's syndrome. Radiol Bras. 2019;52:410-1.
Avelino
EBP
Verza
L
Neves
T
Lymphocytic interstitial pneumonia and pulmonar amyloidosis in Sjögren's syndrome
Radiol Bras
2019
52
410
411
31
31 Barbosa PNVP, Bitencourt AGV, Miranda GD, et al. Chest CT accuracy in the diagnosis of SARS-CoV-2 infection: initial experience in a cancer center. Radiol Bras. 2020;53:211-5.
Barbosa
PNVP
Bitencourt
AGV
Miranda
GD
Chest CT accuracy in the diagnosis of SARS-CoV-2 infection: initial experience in a cancer center
Radiol Bras
2020
53
211
215
32
32 Müller CIS, Müller NL. Chest CT target sign in a couple with COVID-19 pneumonia. Radiol Bras. 2020 ;53:252-4.
Müller
CIS
Müller
NL
Chest CT target sign in a couple with COVID-19 pneumonia
Radiol Bras
2020
53
252
254
33
33 Louza GF, Nobre LF, Mançano AD, et al. Lymphocytic interstitial pneumonia: computed tomography findings in 36 patients. Radiol Bras. 2020;53:287-92.
Louza
GF
Nobre
LF
Mançano
AD
Lymphocytic interstitial pneumonia: computed tomography findings in 36 patients
Radiol Bras
2020
53
287
292
34
34 Farias LPG, Strabelli DG, Fonseca EKUN, et al. Thoracic tomographic manifestations in symptomatic respiratory patients with COVID-19. Radiol Bras. 2020;53:255-61.
Farias
LPG
Strabelli
DG
Fonseca
EKUN
Thoracic tomographic manifestations in symptomatic respiratory patients with COVID-19
Radiol Bras
2020
53
255
261
35
35 Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188:1622-35.
Koh
DM
Collins
DJ
Diffusion-weighted MRI in the body: applications and challenges in oncology
AJR Am J Roentgenol
2007
188
1622
1635
36
36 Chawla S, Kim S, Wang S, et al. Diffusion-weighted imaging in head and neck cancers. Future Oncol. 2009;5:959-75.
Chawla
S
Kim
S
Wang
S
Diffusion-weighted imaging in head and neck cancers
Future Oncol
2009
5
959
975
37
37 Chen L, Liu M, Bao J, et al. The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis. PLoS One. 2013;8:e79008.
Chen
L
Liu
M
Bao
J
The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis
PLoS One
2013
8
e79008
38
38 Xu L, Tian J, Liu Y, et al. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC). J Magn Reson Imaging. 2014;40:200-5.
Xu
L
Tian
J
Liu
Y
Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC)
J Magn Reson Imaging
2014
40
200
205
39
39 Wu LM, Xu JR, Gu HY, et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res. 2012;178:304-14.
Wu
LM
Xu
JR
Gu
HY
Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
J Surg Res
2012
178
304
314
40
40 Baxter GC, Graves MJ, Gilbert FJ, et al. A meta-analysis of the diagnostic performance of diffusion MRI for breast lesion characterization. Radiology. 2019;291:632-41.
Baxter
GC
Graves
MJ
Gilbert
FJ
A meta-analysis of the diagnostic performance of diffusion MRI for breast lesion characterization
Radiology
2019
291
632
641
41
41 Chen L, Zhang J, Bao J, et al. Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions. J Magn Reson Imaging. 2013;37:1351-8.
Chen
L
Zhang
J
Bao
J
Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions
J Magn Reson Imaging
2013
37
1351
1358
42
42 Mesmann C, Sigovan M, Berner LP, et al. Evaluation of image quality of DWIBS versus DWI sequences in thoracic MRI at 3T. Magn Reson Imaging. 2014;32:1237-41.
Mesmann
C
Sigovan
M
Berner
LP
Evaluation of image quality of DWIBS versus DWI sequences in thoracic MRI at 3T
Magn Reson Imaging
2014
32
1237
1241
43
43 Humphries PD, Sebire NJ, Siegel MJ, et al. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007;245:848-54.
Humphries
PD
Sebire
NJ
Siegel
MJ
Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity
Radiology
2007
245
848
854
44
44 Feuerlein S, Pauls S, Juchems MS, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol. 2009;193:1070-6.
Feuerlein
S
Pauls
S
Juchems
MS
Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy
AJR Am J Roentgenol
2009
193
1070
1076
45
45 Desprechins B, Stadnik T, Koerts G, et al. Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. AJNR Am J Neuroradiol. 1999;20:1252-7.
Desprechins
B
Stadnik
T
Koerts
G
Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses
AJNR Am J Neuroradiol
1999
20
1252
1257
46
46 Ohno Y, Niwa T, Nakanishi K, et al. Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med. 2010;51:1549-58.
Ohno
Y
Niwa
T
Nakanishi
K
Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications
J Nucl Med
2010
51
1549
1558
Autoria
Francisco de Souza Santos Correspondence: Dr. Francisco de Souza Santos. Brain Institute of Rio Grande do Sul (BraIns). Avenida Ipiranga, 6690, Petrópolis. Porto Alegre, RS, Brazil, 90610-000. Email: franciscodesouzasantos@gmail.com.
Graduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)BrazilPorto Alegre, RS, BrazilGraduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Department of Radiology, University of Florida (UF), Gainesville, FL, USA.University of Florida (UF)USAGainesville, FL, USADepartment of Radiology, University of Florida (UF), Gainesville, FL, USA.
Graduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)BrazilPorto Alegre, RS, BrazilGraduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Department of Radiology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.Universidade Federal do Rio de Janeiro (UFRJ)BrazilRio de Janeiro, RJ, BrazilDepartment of Radiology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Department of Radiology, University of Florida (UF), Gainesville, FL, USA.University of Florida (UF)USAGainesville, FL, USADepartment of Radiology, University of Florida (UF), Gainesville, FL, USA.
Graduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)BrazilPorto Alegre, RS, BrazilGraduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Graduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)BrazilPorto Alegre, RS, BrazilGraduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Correspondence: Dr. Francisco de Souza Santos. Brain Institute of Rio Grande do Sul (BraIns). Avenida Ipiranga, 6690, Petrópolis. Porto Alegre, RS, Brazil, 90610-000. Email: franciscodesouzasantos@gmail.com.
SCIMAGO INSTITUTIONS RANKINGS
Graduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)BrazilPorto Alegre, RS, BrazilGraduate Program in Internal Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Department of Radiology, University of Florida (UF), Gainesville, FL, USA.University of Florida (UF)USAGainesville, FL, USADepartment of Radiology, University of Florida (UF), Gainesville, FL, USA.
Department of Radiology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.Universidade Federal do Rio de Janeiro (UFRJ)BrazilRio de Janeiro, RJ, BrazilDepartment of Radiology, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Figure 3
Forest plots of the sensitivity and specificity of DWI for differentiating between malignant and benign thoracic lymph nodes. Heterogeneity was high, as evidenced by the I2 value, which was 82%, values over 75% being considered indicative of high heterogeneity.
Figure 4
Conditional probability plot of the ability of DWI to differentiate between malignant and benign mediastinal lymph nodes. LR, likelihood ratio.
Figure 5
Receiver operating characteristic curve for DWI. AUC suggest a high diagnostic performance. Numbers within circles represent the studies referenced.
imageFigure 1
PRISMA flow chart detailing the search and article selection processes.
open_in_new
imageFigure 2
QUADAS-2 summary. The overall QUADAS-2 score for the articles selected suggests that they were of high quality.
open_in_new
imageFigure 3
Forest plots of the sensitivity and specificity of DWI for differentiating between malignant and benign thoracic lymph nodes. Heterogeneity was high, as evidenced by the I2 value, which was 82%, values over 75% being considered indicative of high heterogeneity.
open_in_new
imageFigure 4
Conditional probability plot of the ability of DWI to differentiate between malignant and benign mediastinal lymph nodes. LR, likelihood ratio.
open_in_new
imageFigure 5
Receiver operating characteristic curve for DWI. AUC suggest a high diagnostic performance. Numbers within circles represent the studies referenced.
open_in_new
table_chartTable 1
Summary of the studies selected.
Santos, Francisco de Souza et al. Ressonância magnética ponderada em difusão para a diferenciação entre linfonodos torácicos malignos de benignos: uma meta-análise. Radiologia Brasileira [online]. 2021, v. 54, n. 4 [Acessado 3 Abril 2025], pp. 225-231. Disponível em: <https://doi.org/10.1590/0100-3984.2020.0084>. Epub 19 Jul 2021. ISSN 1678-7099. https://doi.org/10.1590/0100-3984.2020.0084.
Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por ImagemAv. Paulista, 37 - 7º andar - conjunto 71, 01311-902 - São Paulo - SP, Tel.: +55 11 3372-4541, Fax: 3285-1690, Fax: +55 11 3285-1690 -
São Paulo -
SP -
Brazil E-mail: radiologiabrasileira@cbr.org.br
rss_feed
Acompanhe os números deste periódico no seu leitor de RSS
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.